EmbectaEMBC -0.45%53 Dividend Yield % is 13.73% as of Jul. 06, 2026, which is 232% above its 10-year median of 4.14. GuruFocus rates EMBC with a GF Score™ of 53/100 and a GF Value™ of $12.68 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 328 Medical Devices & Instruments companies, Embecta ranks better than 99.09% on this metric.
As of today (2026-07-06), the Trailing Annual Dividend Yield of Embecta is 13.73%.
The historical rank and industry rank for Embecta's Dividend Yield % or its related term are showing as below:
EMBC'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.44 Med: 4.14 Max: 19.35
Current: 13.73
During the past 7 years, the highest Dividend Yield of Embecta was 19.35%. The lowest was 0.44%. And the median was 4.14%.
EMBC's Dividend Yield % is ranked better than 99.09% of 328
companies
in the Medical Devices & Instruments industry
Industry Median: 1.91
vs EMBC: 13.73
During the past 3 years, the average Dividends Per Share Growth Rate was 58.70% per year.
During the past 7 years, the highest 3-Year average Dividends Per Share Growth Rate of Embecta was 58.70% per year. The lowest was 58.70% per year. And the median was 58.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Embecta (NAS:EMBC) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Embecta's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EMBC vs KRMD, SMTI, PDEX: Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Embecta's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embecta Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Embecta's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Embecta Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.010000
2026-05-28
2026-05-28
2026-06-15
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.150000
2026-02-27
2026-02-27
2026-03-17
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.150000
2025-12-05
2025-12-05
2025-12-18
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.150000
2025-08-29
2025-08-29
2025-09-15
Cash Dividend
quarterly
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Embecta's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.46
/
3.35
=
13.73 %
Current Share Price is $3.35. Embecta's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.46.
Embecta's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.04
/
3.35
=
1.19 %
Current Share Price is $3.35. Embecta's Dividends per Share for the forward twelve months is calculated as $0.01 * 4 = $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta (EMBC) has a Dividend Yield % of 13.73% as of Jul. 06, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Embecta and its competitors. This is 232% above median its historical median of 4.14. Over the past decade, Embecta's Dividend Yield % has ranged from 0.44 to 19.35. According to the industry distribution chart, Embecta ranks #3 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 0.90000000000001%.
Is Embecta's Dividend Yield % too high?
Embecta's current Dividend Yield % of 13.73% is 232% above median its 10-year median of 4.14. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 19.35. The Medical Devices & Instruments industry median Dividend Yield % is 1.91. Embecta's value of 13.73% is 618.8% above this industry median. Based on the distribution chart, Embecta ranks #3 out of 328 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Embecta has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Embecta's Dividend Yield % compare to KRMD and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Embecta ranks #3 out of 328 companies for Dividend Yield %. This places Embecta in the top 1% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.91. Embecta's value of 13.73% is 618.8% above this benchmark. Historically, Embecta's own Dividend Yield % has ranged from 0.44 to 19.35 over the past decade. While the company's 10-year median is 4.14 vs. the industry median of 1.91, Embecta has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.91, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embecta's current Dividend Yield % of 13.73% is 618.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Embecta and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embecta's current Dividend Yield % is 13.73%, which is 232% above median its own 10-year median of 4.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embecta stock overvalued right now?
Based on GuruFocus' analysis, Embecta (EMBC) is currently considered Possible Value Trap. The stock's GF Value™ is $12.68, compared to a current price of $3.35 — trading 73.6% below its estimated fair value. The current Dividend Yield % is 13.73%, which is 232% above median its 10-year median of 4.14 and 618.8% above the Medical Devices & Instruments industry median of 1.91. Embecta's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Embecta (EMBC), the current Dividend Yield % is 13.73% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embecta (EMBC) Overvalued in 2026?
Based on GuruFocus' analysis, Embecta stock appears to be undervalued.
The current stock price of $3.35 is trading 73.6% below its estimated GF Value™ of $12.68.
GuruFocus considers Embecta to be Possible Value Trap.
Key valuation signals for EMBC:
Dividend Yield %: 13.73% (232% above median its 10-year median of 4.14)
GF Value™: $12.68 vs. price of $3.35 (73.6% below fair value)
Industry Position: 618.8% above the Medical Devices & Instruments median (#3 of 328)
No single metric tells the full story. See the EMBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
53GF Score
Get the complete analysis for EMBC
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EMBC has been successfully added to your 
